Skip to main content Skip to section navigation Skip to footer
Axogen Corporate Home
    • About Us
    • Management Team
    • Board of Directors
    • Careers
    • Organizations We Work With
    • Grants, Donations and Sponsorships
    • Ethics and Compliance
    • Patents
  • For healthcare professionals
  • For patients
  • For investors
Skip to main content Skip to section navigation Skip to footer
Axogen, Inc. IR Overview
  • Overview
  • News/Events
    • News / Events Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Information
    • Financial Information Overview
    • Financial Results
    • Balance Sheet
    • Income Statement
    • Cash Flow
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Information
    • Contacts
    • FAQ

Press Releases

Investors

  • Overview
  • News/Events
    • News / Events Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Information
    • Financial Information Overview
    • Financial Results
    • Balance Sheet
    • Income Statement
    • Cash Flow
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Information
    • Contacts
    • FAQ

  • News/Events

  • News / Events Overview
  • Press Releases
  • Axogen In the News
  • IR Calendar
  • Clinical Conferences
  • Presentations
  • Email Alerts
Jan 24, 2019 7:00 am EST
AxoGen to Participate at AAHS ASPN ASRM 2019 Annual Meetings
Jan 22, 2019 7:00 am EST
AxoGen Appoints Eric Sandberg as Chief Commercial Officer
Jan 15, 2019 8:00 am EST
AxoGen Announces RECON® Study Update
Jan 7, 2019 9:00 am EST
AxoGen Appoints Christopher Crisman as Vice President, U.S. Sales
Jan 7, 2019 9:00 am EST
AxoGen, Inc. Pre-Announces Financial and Operational Results
Dec 6, 2018 7:00 am EST
AxoGen Announces Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float
Nov 19, 2018 8:23 am EST
AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day
Nov 6, 2018 7:00 am EST
AxoGen to Host Third Annual Analyst and Investor Day on November 19, 2018
Oct 29, 2018 4:01 pm EDT
AxoGen, Inc. Reports 2018 Third Quarter Financial Results
Oct 29, 2018 4:00 pm EDT
Avance® Nerve Graft Receives Regenerative Medicine Advanced Therapy (RMAT) Designation
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • …
  • Page 36
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
  • accessibilityAccessibility Statement
Axogen Corporate Home

13631 Progress Blvd, Suite 400
Alachua, FL 32615

Audience
  • For Healthcare Professionals
  • For Patients
  • For Investors
Resources
  • Privacy Policy
  • Terms and Conditions
  • Website Terms of Use
  • Medical Information
Corporate
  • About Axogen
  • Careers
  • Contact
  • News
YouTube company logo LinkedIn company logo Instagram company logo Facebook company logo X company logo

© 2026 Axogen Corporation. All Rights Reserved. All trademarks are the property of their respective owners. See Trademark & Copyright Notice for details.